Caption Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-83,500
Closed -$1.54M 1556
2025
Q3
$1.54M Sell
83,500
-4,400
-5% -$70.7K 0.01% 942
2025
Q2
$1.14M Buy
+87,900
New +$1.04M 0.01% 895
2025
Q1
Sell
-30,000
Closed -$509K 1497
2024
Q4
$509K Buy
+30,000
New +$565K ﹤0.01% 1102
2024
Q3
Sell
-60,000
Closed -$1.46M 1259
2024
Q2
$1.46M Sell
60,000
-25,000
-29% -$758K 0.02% 555
2024
Q1
$2.87M Sell
85,000
-5,000
-6% -$177K 0.04% 438
2023
Q4
$2.84M Buy
90,000
+30,000
+50% +$713K 0.04% 512
2023
Q3
$1.53M Buy
+60,000
New +$1.85M 0.02% 650
2023
Q2
Sell
-30,000
Closed -$719K 1090
2023
Q1
$719K Buy
+30,000
New +$538K 0.01% 703
2022
Q4
Sell
-30,000
Closed -$444K 1261
2022
Q3
$444K Hold
30,000
0.01% 1093
2022
Q2
$472K Buy
30,000
+20,000
+200% +$392K 0.01% 1086
2022
Q1
$268K Hold
10,000
﹤0.01% 1235
2021
Q4
$370K Hold
10,000
﹤0.01% 1317
2021
Q3
$478K Buy
+10,000
New +$448K 0.01% 1206

Other funds holding ARCT